Biological Variation of Lipoprotein(a) in a Diabetic Population. Analysis of the Causes and Clinical Implications

Verfasser / Beitragende:
[Cristina Hernández, Gemma Francisco, Pilar Chacón, Jordi Mesa, Rafael Simó]
Ort, Verlag, Jahr:
2003
Enthalten in:
Clinical Chemistry and Laboratory Medicine, 41/8(2003-08-07), 1075-1080
Format:
Artikel (online)
ID: 378881523
LEADER caa a22 4500
001 378881523
003 CHVBK
005 20180305123433.0
007 cr unu---uuuuu
008 161128e20030807xx s 000 0 eng
024 7 0 |a 10.1515/CCLM.2003.166  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/CCLM.2003.166 
245 0 0 |a Biological Variation of Lipoprotein(a) in a Diabetic Population. Analysis of the Causes and Clinical Implications  |h [Elektronische Daten]  |c [Cristina Hernández, Gemma Francisco, Pilar Chacón, Jordi Mesa, Rafael Simó] 
520 3 |a The aims of the present study were to evaluate the biological variability of lipoprotein(a) (Lp(a)) in diabetic patients and to investigate the biological sources of this variability. Lp(a) was measured by ELISA in four serum specimens collected in 3-month intervals from 70 patients. The other parameters analyzed were: total cholesterol, high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-cholesterol (LDL-C), triglycerides, glucose, HbA and albumin excretion rate. The overall biological within-subject variance (CVb) was 31.7%, and it was inversely correlated with Lp(a) serum levels. According to the initial ranges of Lp(a) serum levels (<15, 15-30 and >30mg/dl) the CVb were 42.3%, 24.1% and 23.7%, respectively. In multivariate analysis the total intra-individual coefficient of variation (CVt) of triglycerides and the CVt of the albumin excretion rate (AER) were independently associated with the CVb of Lp(a) (R2 =0.54). The intra-individual biological variation of Lp(a) produced a misclassification of 20% of diabetic patients for cardiovascular risk attributable to this lipoprotein. In conclusion, the higher biological variability of Lp(a) observed in diabetic patients suggests that a single determination could be inaccurate to assess the cardiovascular risk associated with this lipoprotein, at least in those patients in whom serum levels are near the cut-off considered as risk for cardiovascular disease (>30 mg/dl). Finally, triglycerides and AER are the main factors influencing Lp(a) serum levels in the diabetic population. 
540 |a Copyright © 2003 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Medical equipment & techniques  |2 nationallicence 
690 7 |a Medical diagnosis  |2 nationallicence 
690 7 |a Diseases & disorders  |2 nationallicence 
700 1 |a Hernández  |D Cristina  |4 aut 
700 1 |a Francisco  |D Gemma  |4 aut 
700 1 |a Chacón  |D Pilar  |4 aut 
700 1 |a Mesa  |D Jordi  |4 aut 
700 1 |a Simó  |D Rafael  |4 aut 
773 0 |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 41/8(2003-08-07), 1075-1080  |x 1434-6621  |q 41:8<1075  |1 2003  |2 41  |o cclm 
856 4 0 |u https://doi.org/10.1515/CCLM.2003.166  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/CCLM.2003.166  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Hernández  |D Cristina  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Francisco  |D Gemma  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Chacón  |D Pilar  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Mesa  |D Jordi  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Simó  |D Rafael  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Clinical Chemistry and Laboratory Medicine  |d Walter de Gruyter  |g 41/8(2003-08-07), 1075-1080  |x 1434-6621  |q 41:8<1075  |1 2003  |2 41  |o cclm 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter